A Study to Evaluate the Effects of Various Degrees of Hepatic Impairment on the Pharmacokinetics of A Single Subcutaneous Dose Of RO7434656, an Antisense Inhibitor of Complement Factor B

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508270-29-01

Acronym

WA45032

Enrollment

Registered

2024-07-31

Start date

2024-09-24

Completion date

2025-10-07

Last updated

2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Impairment

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Poland, Slovakia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026